Clinical-economic impact of mepolizumab in patients with severe hypereosinophilic asthma

Clinical-economic impact of mepolizumab in patients with severe hypereosinophilic asthma

Bibliographic Details
Main Authors:	Diego Bagnasco, Massimiliano Povero, Lorenzo Pradelli, Enrico Heffler, Marco Caminati, Francesco Menzella, Giovanni Rolla, Manlio Milanese, Carlo Lombardi, Elisa Testino, Gianenrico Senna, Giorgio Walter Canonica, Giovanni Passalacqua
Format:	Article
Language:	English
Published:	Elsevier 2020-08-01
Series:	World Allergy Organization Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S1939455120302799

Similar Items

Efficacy of Mepolizumab in patients with previous Omalizumab treatment failure: real life observation
by: Diego Bagnasco, et al.
Published: (2020-08-01)

Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience
by: Gilda Varricchi, et al.
Published: (2017-01-01)

Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases
by: Menzella F, et al.
Published: (2015-10-01)

The North-Western Italian experience with anti IL-5 therapy amd comparison with regulatory trials
by: Diego Bagnasco, et al.
Published: (2018-12-01)

Long-term responsiveness to mepolizumab after failure of omalizumab and bronchial thermoplasty: Two triple-switch case reports
by: Carlo Lombardi, et al.
Published: (2020-01-01)

Dysphonia and dyspnea in idiopathic hypereosinophilic syndrome treated with Mepolizumab
by: Dana Kay, et al.
Published: (2018-01-01)

Anti-IL-5 and IL-5Ra: Efficacy and Safety of New Therapeutic Strategies in Severe Uncontrolled Asthma
by: Diego Bagnasco, et al.
Published: (2018-01-01)

Idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab
by: Koki Fujii, et al.
Published: (2020-11-01)

Clinical usefulness of mepolizumab in severe eosinophilic asthma
by: Menzella F, et al.
Published: (2016-06-01)

Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life
by: Diego Bagnasco, et al.
Published: (2021-02-01)

Minimal clinically important difference for asthma endpoints: an expert consensus report
by: Matteo Bonini, et al.
Published: (2020-06-01)

Therapeutic interventions in severe asthma
by: Giorgio Walter Canonica, et al.
Published: (2016-01-01)

Nasal polyps impact in severe asthma patients: evidences from the SANI
by: Giorgio Walter Canonica, et al.
Published: (2020-08-01)

Near-fatal asthma responsive to mepolizumab after failure of omalizumab and bronchial thermoplasty
by: Menzella F, et al.
Published: (2017-11-01)

Mepolizumab in the treatment of bronchial asthma in children
by: Yu. L. Mizernitskiy, et al.
Published: (2020-03-01)

Type 2 immunity in asthma
by: Marco Caminati, et al.
Published: (2018-06-01)

Interleukin-5 in the Pathophysiology of Severe Asthma
by: Corrado Pelaia, et al.
Published: (2019-12-01)

Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma
by: Giovanna Elisiana Carpagnano, et al.
Published: (2021-03-01)

A critical appraisal on AIT in childhood asthma
by: Matteo Ferrando, et al.
Published: (2018-03-01)

Is allergic sensitization relevant in severe asthma? Which allergens may be culprits?
by: Carlo Lombardi, et al.
Published: (2017-01-01)

Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma
by: Diego Bagnasco, et al.
Published: (2017-08-01)

Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
by: Steven W. Yancey, et al.
Published: (2019-09-01)

Childhood-onset severe hypereosinophilic asthma: efficacy of benralizumab
by: Jocelyne Just, et al.
Published: (2020-12-01)

Personalized Approach to Severe Asthma
by: Enrico Heffler, et al.
Published: (2018-01-01)

Clinical efficacy of mepolizumab in the treatment of severe eosinophilic asthma in children
by: V. N. Drozdov, et al.
Published: (2020-11-01)

Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis
by: Takanori Numata, et al.
Published: (2019-10-01)

Efficacy and safety of mepolizumab in Japanese patients with severe eosinophilic asthma
by: Terufumi Shimoda, et al.
Published: (2017-07-01)

Patient profiles and clinical utility of mepolizumab in severe eosinophilic asthma
by: Haldar P
Published: (2017-06-01)

SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma
by: G. Senna, et al.
Published: (2017-04-01)

Economic evaluation and budgetary burden of mepolizumab in severe refractory eosinophilic asthma
by: Manuel David Gil-Sierra, et al.
Published: (2019-11-01)

Self-Administered Mepolizumab in the Management of Severe Asthma: Usability and Patient Acceptance
by: Miyokawa R, et al.
Published: (2020-09-01)

Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions
by: Peter G. Gibson, et al.
Published: (2021-06-01)

Response to Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma and Atopic Phenotypes
by: Prazma CM, et al.
Published: (2021-06-01)

New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic
by: Caminati M, et al.
Published: (2019-05-01)

Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry
by: Puggioni F, et al.
Published: (2020-11-01)

Local Nasal Specific Immunotherapy for Allergic Rhinitis
by: Passalacqua Giovanni, et al.
Published: (2006-09-01)

Impact of rhinitis on airway inflammation: biological and therapeutic implications
by: Canonica Giorgio, et al.
Published: (2001-09-01)

Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis
by: Enrico Heffler, et al.
Published: (2020-06-01)

Physicians’ prescribing behaviour and clinical practice patterns for allergic rhinitis management in Italy
by: Giovanni Passalacqua, et al.
Published: (2020-11-01)

The control of allergic rhinitis in real life: a multicenter cross-sectional Italian study
by: Federica Gani, et al.
Published: (2018-02-01)

Cannot write session to /tmp/vufind_sessions/sess_s5rq17pm7j1rgcn9cj1g9a5q86